Medexprim Appoints Alexandre Blanchot as Business Development Manager

Medexprim has appointed Alexandre Blanchot as Business Development Manager.

Alexandre has a translational experience of the drug development sectors from discovery to clinical development and commercialization of innovative therapies, the company said.

Romain Cazavan, CEO: “Alexandre’s knowledge of the Life Sciences and Healthcare markets as well as his experience in international collaboration will be valuable for Medexprim, while Real-World Evidence turns to be a critical asset for the Life Science Industry to accelerate drug development and reduce costs.”

Alexandre Blanchot: “I am very excited to join Medexprim’s team as the company brings a unique value proposition to the Life Sciences Industry to collect Real-World evidence data from patients, with the highest standards of compliance. Medical Imaging has the potential to drastically transform the way we develop and accelerate drug and devices to patients. Medexprim is perfectly positioned to support private / public collaboration towards a unique goal: shortening access of new solution from bench to patients’ bed”.